Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-394.45%
↓ 389% below average
Average (34q)
-80.73%
Historical baseline
Range
High:252.45%
Low:-982.09%
Volatility
-1529.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -394.45% |
| Q2 2025 | 84.86% |
| Q1 2025 | -4.87% |
| Q4 2024 | -48.49% |
| Q3 2024 | -1.60% |
| Q2 2024 | 17.51% |
| Q1 2024 | -287.39% |
| Q4 2023 | 163.03% |
| Q3 2023 | -27.93% |
| Q2 2023 | 23.03% |
| Q1 2023 | -44.68% |
| Q4 2022 | -77.51% |
| Q3 2022 | 25.08% |
| Q2 2022 | 33.49% |
| Q1 2022 | -2.58% |
| Q4 2021 | -23.37% |
| Q3 2021 | -402.31% |
| Q2 2021 | 79.74% |
| Q1 2021 | 49.01% |
| Q4 2020 | -447.42% |
| Q3 2020 | -42.63% |
| Q2 2020 | 252.45% |
| Q1 2020 | -32.50% |
| Q4 2019 | -14.54% |
| Q3 2019 | 6.39% |
| Q2 2019 | 3.21% |
| Q1 2019 | -854.45% |
| Q4 2018 | 85.42% |
| Q3 2018 | 11.30% |
| Q2 2018 | 4.19% |
| Q1 2018 | 21.49% |
| Q4 2017 | -982.09% |
| Q3 2017 | 3.08% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |